Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain

Clinical and Experimental Rheumatology

Volumn 28, Issue 1, 2010, Pages 68-72

  Palomino Morales, R ^a   Gonzalez Juanatey, C ^b   Vazquez Rodriguez, T R ^b   Torres, O ^a   Miranda Filloy, J A ^b   Llorca, J ^c   Martin, J ^a   Gonzalez Gay, Miguel A ^b  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Atherosclerosis; Cardiovascular disease; Genetics; MIF 173; Rheumatoid arthritis

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SPAIN;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SPAIN; TUNICA INTIMA; TUNICA MEDIA;

EID: 77949521929     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, MARTIN J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005; 35: 8-17.
2. DESSEIN PH, JOFFE BI, VELLER MG et al.: Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005; 32: 435-42.
3. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, LOPEZ-DIAZ MJ et al.: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
4. ZERNECKE A, BERNHAGEN J, WEBER C: Macrophage migration inhibitory factor incardiovascular disease. Circulation 2008; 117: 1594-602.
5. LIEW FY: Regulation of nitric oxide synthesis in infectious and autoimmune diseases. Immunol Lett 1994; 43: 95-8.
6. LEECH M, METZ C, HALL P et al.: Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 1999; 42: 1601-8.
7. BERNHAGEN J, KROHN R, LUE H et al.: MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 2007; 13: 587-96.
8. MARTINEZ A, OROZCO G, VARADE J et al.: Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol 2007; 68:744-7.
9. RADSTAKE TR, SWEEP FC, WELSING P et al.: Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum 2005; 52: 3020-9.
10. DONN RP, SHELLEY E, OLLIER WE, THOMSON W: A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782-5.
11. SÁNCHEZ E, GÓMEZ LM, LOPEZ-NEVOT MA et al.: Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006; 7:433-6.
12. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
13. GONZALEZ-GAY MA, GARCIA-PORRUA C, GUERRERO J et al.: The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003; 49: 388-93.
14. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, VAZQUEZ-RODRIGUEZ TR et al.: Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 2008; 38: 67-70.
15. AMOLI MM, MARTIN J, MIRANDA-FILLOY JA et al.: Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis. Clin Exp Rheumatol 2006; 24: 576-9.
16. LÉVY L, FAUTREL B, BARNETCHE T et al.: Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 2008; 26: 673-9.
17. GONZALEZ-GAY MA, LLORCA J, PALOMINOMORALES R et al.: Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 116-9.
18. HERDER C, ILLIG T, BAUMERT J et al.: Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis 2008; 200: 380-8.
19. TERESHCHENKO IP, PETRKOVA J, MRAZEK F et al.: The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction. Clin Chim Acta 2009; 402: 199-202.